The diffusion capacity of the lung for carbon monoxide (DLCO) is used to measure the body's ability to transfer oxygen across the alveolar-capillary membrane. [1] Internists use this test to identify ...
CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that ...
In April 2022, Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) announced that dosing was completed in the Altitude Trial. It is a double blind, randomized, placebo controlled trial to evaluate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback